Stoxx Europe 50

Stoxx Europe 50 handeln
4.915,52 PKT +73,51 PKT +1,52 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Smartphone

WKN 965816

ISIN EU0009658160


Analysen zu Stoxx Europe 50-Werten

Datum Rating Analyst
01.04.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
01.04.22 Deutsche Telekom Overweight Barclays Capital
01.04.22 Novartis Underweight JP Morgan Chase & Co.
01.04.22 BNP Paribas Neutral JP Morgan Chase & Co.
01.04.22 UBS Overweight JP Morgan Chase & Co.
01.04.22 UBS Underweight JP Morgan Chase & Co.
01.04.22 GSK Neutral JP Morgan Chase & Co.
01.04.22 Novo Nordisk Neutral Credit Suisse Group
01.04.22 Intesa Sanpaolo Neutral Credit Suisse Group
01.04.22 Santander Outperform Credit Suisse Group
01.04.22 UBS Outperform Credit Suisse Group
01.04.22 BBVA Neutral Credit Suisse Group
01.04.22 BNP Paribas Outperform Credit Suisse Group
31.03.22 Schneider Electric Overweight JP Morgan Chase & Co.
31.03.22 Rheinmetall Buy Deutsche Bank AG
31.03.22 Roche Buy Deutsche Bank AG
31.03.22 BBVA Hold Deutsche Bank AG
31.03.22 LOréal Overweight JP Morgan Chase & Co.
31.03.22 SAP Outperform Credit Suisse Group
31.03.22 Siemens Buy Jefferies & Company Inc.
31.03.22 HSBC Buy Goldman Sachs Group Inc.
31.03.22 BBVA Neutral Goldman Sachs Group Inc.
31.03.22 Santander Buy Goldman Sachs Group Inc.
31.03.22 UBS Neutral Goldman Sachs Group Inc.
31.03.22 UBS Buy Goldman Sachs Group Inc.
31.03.22 Siemens Overweight JP Morgan Chase & Co.
30.03.22 Unilever Outperform Credit Suisse Group
30.03.22 Sanofi Outperform Credit Suisse Group
30.03.22 Nestlé Neutral Credit Suisse Group
30.03.22 Roche Overweight Barclays Capital
30.03.22 Roche Buy Merrill Lynch & Co., Inc.
30.03.22 Sanofi Buy UBS AG
30.03.22 Iberdrola SA Buy Goldman Sachs Group Inc.
30.03.22 Enel Conviction Buy List Goldman Sachs Group Inc.
30.03.22 AstraZeneca Buy Deutsche Bank AG
30.03.22 Roche Neutral JP Morgan Chase & Co.
30.03.22 Roche Conviction Buy List Goldman Sachs Group Inc.
30.03.22 Roche Outperform Bernstein Research
30.03.22 UBS Sector Perform RBC Capital Markets
30.03.22 UBS Outperform RBC Capital Markets